1 01/07/2024 30/06/2025 2025-06-30 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-07-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 14972877 2024-07-01 2025-06-30 14972877 2025-06-30 14972877 2024-06-30 14972877 2023-07-01 2024-06-30 14972877 2024-06-30 14972877 2023-06-30 14972877 bus:RegisteredOffice 2024-07-01 2025-06-30 14972877 bus:LeadAgentIfApplicable 2024-07-01 2025-06-30 14972877 bus:Director1 2024-07-01 2025-06-30 14972877 core:WithinOneYear 2025-06-30 14972877 core:WithinOneYear 2024-06-30 14972877 bus:Micro-entities 2024-07-01 2025-06-30 14972877 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 14972877 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 14972877 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 14972877 bus:FullAccounts 2024-07-01 2025-06-30
Company registration number: 14972877
ASJ PHARMA LIMITED
Unaudited filleted financial statements
30 June 2025
ASJ PHARMA LIMITED
Contents
Directors and other information
Accountants report
Statement of financial position and notes to the financial statements
ASJ PHARMA LIMITED
Directors and other information
Director Mr Aarondeep Singh Johal
Company number 14972877
Registered office 3 Alloa Road
Goodmayes
Ilford
England
IG3 9SW
Business address 3 Alloa Road
Goodmayes
Ilford
England
IG3 9SW
Accountants Xeinadin London Limited (Ilford)
616d Green Lane
Ilford
IG3 9SE
ASJ PHARMA LIMITED
Chartered accountants report to the director on the preparation of the
unaudited statutory financial statements of ASJ PHARMA LIMITED
Year ended 30 June 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of ASJ PHARMA LIMITED for the year ended 30 June 2025 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the director of ASJ PHARMA LIMITED, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of ASJ PHARMA LIMITED and state those matters that we have agreed to state to them, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than ASJ PHARMA LIMITED and its director as a body for our work or for this report.
It is your duty to ensure that ASJ PHARMA LIMITED has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of ASJ PHARMA LIMITED. You consider that ASJ PHARMA LIMITED is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of ASJ PHARMA LIMITED. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Xeinadin London Limited (Ilford)
616d Green Lane
Ilford
IG3 9SE
30 December 2025
ASJ PHARMA LIMITED
Statement of financial position
30 June 2025
30/06/25 30/06/24
£ £
Fixed assets 6,743 1,996
_______ _______
Current assets 50,848 48,641
Creditors: amounts falling due within one year ( 47,577) ( 38,400)
_______ _______
Net current assets 3,271 10,241
_______ _______
Total assets less current liabilities 10,014 12,237
Accruals and deferred income ( 1,560) ( 1,200)
_______ _______
Net assets 8,454 11,037
_______ _______
Capital and reserves 8,454 11,037
_______ _______
Notes to the financial statements
ASJ PHARMA LIMITED
Year ended 30 June 2025
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
2. Directors advances, credits and guarantees
There were no advances as at the period ended 30 June 2025.
For the year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The director acknowledges responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 30 December 2025 , and are signed on behalf of the board by:
Mr Aarondeep Singh Johal
Director
Company registration number: 14972877
The company is a private company limited by shares, registered in England.